Working on the public Human Genome Project, Craig Venter
Interviewee: Craig Venter. Craig Venter speaks about the public sector's reaction to his plans to sequence the genome at a private company, Celera Genomics. (DNAi Location: Genome > The Project > Players > Money > Threatening their funding)
I think the scientists who claimed that they were going to do this public program almost started to believe it was their birthright to get all this money and take the next several decades to do this project. I think the scientists were around this public effort because it was a massive effort to get billions of dollars in committed funding. This was the first time this has ever happened in biology.
human genome project,company celera,public effort,massive effort,craig venter,interviewee,birthright,genomics,private company,billions of dollars,public sector,scientists,biology,decades,money
Craig Venter, leader of the private effort at Celera Genomics, speaks about his company's reliance on the public data for reassembly of the Celera sequence.
The leaders of the private and public genome projects, Craig Venter and Francis Collins.
Craig Venter, leader of the private effort at Celera Genomics, speaks about the excitement the race to sequence the human genome generated.
Craig Venter, the leader of the private genome effort at Celera Genomics, talks about the differences between the public and private approaches.
Ari Patrinos, director of the U.S. Department of Energy's sequencing effort, talks about the private genome project announcement and public funding.
Craig Venter, the leader of the private genome effort, talks about the "whole genome shotgun" technique that was used by Celera Genomics to sequence the human genome.
Craig Venter, the leader of the private genome effort at Celera Genomics, talks about the sources of the DNA used in their sequence.
Craig Venter talks about the public won the race.
Ari Patrinos, director of the US Department of Energy's sequencing effort, talks about the public genome project's aims that extended beyond those of the private project.
Eric Lander talks about analysis in public and private Human Genome Projects.